Svenska Handelsbanken’s Allergan plc AGN Stock Holding History

Svenska Handelsbanken’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,800	Closed	-$378K	–	72
2016 Q4	$378K	Hold	1,800	–	–	0.02%	60
2016 Q3	$415K	Buy	+1,800	New	+$440K	0.03%	83

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Svenska Handelsbanken's AGN Position: Q1 2017 in Review

Svenska Handelsbanken sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 1,800 shares — an estimated $378K sold.

Svenska Handelsbanken first reported a position in AGN in Q3 2016 and held it in 2 quarters. The position peaked at $415K in Q3 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

Svenska Handelsbanken reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Svenska Handelsbanken sold 1,800 Allergan plc shares in Q1 2017, an estimated $378K.
Svenska Handelsbanken first reported a position in Allergan plc in Q3 2016 and held it in 2 quarters.
Svenska Handelsbanken's Allergan plc position peaked at $415K in Q3 2016.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Svenska Handelsbanken's 13F filing for Q1 2017, filed 10 May 2017.